Mativ
Mativ's revenue rose 0.3% to $2.0 billion in fiscal 2025. Its operating margin was −19.4%, down from 0.3% a year earlier. Free cash flow was $94 million, up 135.7%. It paid out $22 million in dividends and buybacks, 24% of free cash flow. The diluted share count rose 0.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Mativ does
Mativ makes specialty materials for other businesses, combining polymers, fibers and resins to improve its customers' products. It sells into markets such as filtration, healthcare and packaging. It was spun off from Kimberly-Clark in 1995 and was known as Schweitzer-Mauduit until its 2022 merger with Neenah.
It has two reporting segments. Filtration and Advanced Materials focuses mainly on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products. Sustainable and Adhesive Solutions focuses mainly on tapes, labels, liners, specialty paper, packaging and healthcare solutions. Its products are sold around the world, most of all in North America and Europe.
The company manufactures on three continents, does business in over 100 countries and runs 34 production locations. In November 2023 it sold its Engineered Papers business, which made tobacco-related papers, and so it no longer takes part in tobacco-based product markets. That business is shown as a discontinued operation.
Its biggest risks, as it describes them
- Its technological advantages may not last, and its patents and other intellectual property may be challenged.
- International risks from selling and making goods in many countries, including exchange rates and trade rules.
- Further impairment of goodwill, which would reduce its reported results.
- Trouble integrating acquisitions, and restructuring that is costly and could disrupt its business.
- Loss or interruption of the operations of its facilities, and weaker construction and infrastructure spending.
Income statement
From fiscal 2016 to 2021, earnings per share grew 0.7% a year and net income 1.4% a year, as new shares raised the share count by 3% and diluted each share's earnings. Mativ then lost money in fiscal 2022, 2023, 2024 and 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 71 | 101 | 120 | 94 | 84 |
| Debt incl. finance leases | 1,289 | 1,742 | 1,148 | 1,131 | 1,052 |
| Net debt (negative means net cash) | 1,218 | 1,641 | 1,028 | 1,036 | 967 |
| Net debt to EBITDA | 23.9x | 23.5x | — | 6.9x | — |
| Debt to equity | 1.9x | 1.5x | 1.2x | 1.3x | 2.1x |
| Interest coverage | −0.4x | −0.7x | −6.7x | 0.1x | −5.4x |
| Current ratio | 2.6x | 2.1x | 2.5x | 2.4x | 2.2x |
| Quick ratio | 1.4x | 1.2x | 1.3x | 1.1x | 1.1x |
Cash flow
Projections
Project Mativ's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
No officer, director or 10% owner of Mativ reported buying or selling its shares on the open market between November 14, 2025 and November 13, 2026.
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 6 of 9 | 3 of 9 |
| Rule of 40 | 25.8% | −0.2% | 5.0% |
| Altman Z'' | 0.90 | 1.83 | −0.10 |
| Accruals ratio | −13.2% | −5.6% | −20.9% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Fail | Fail |
| Share count didn't rise | Fail | Pass | Fail |
| Gross margin rose | Fail | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 4 of 9 | 6 of 9 | 3 of 9 |
Compare
Put Mativ side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Mativ | FY25 | 0.3% | −19.4% | 4.7% | −18.1% | — | 3 | |
| Magnera | FY25 | — | 0.2% | 1.1% | — | −1.4x | — | Compare |
| Sonoco | FY25 | 41.7% | 13.5% | 4.6% | 9.4% | 2.6x | 5 | Compare |
| Graphic Packaging | FY25 | −2.2% | 9.3% | −0.9% | 7.3% | 4.0x | 4 | Compare |
| Avery Dennison | FY25 | 1.1% | — | 8.0% | 14.6% | 2.5x | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 840 | 982 | 1,041 | 1,023 | 1,074 | 931 | 1,637 | 2,026 | 1,981 | 1,987 |
| Revenue growth | 9.9% | 16.9% | 6.0% | −1.8% | 5.0% | −13.4% | 75.9% | 23.8% | −2.2% | 0.3% |
| Gross profit | 258 | 283 | 278 | 290 | 308 | 183 | 306 | 356 | 364 | 363 |
| Research and development | 18 | 18 | 15 | 14 | 14 | 12 | 19 | 21 | 23 | 24 |
| Operating income | 110 | 128 | 135 | 134 | 129 | −16 | −40 | −414 | 6 | −384 |
| Net income | 83 | 34 | 94 | 86 | 84 | 89 | −7 | −310 | −49 | −337 |
| Diluted EPS (US$) | 2.70 | 1.12 | 3.06 | 2.76 | 2.66 | 2.80 | −0.18 | −5.69 | −0.90 | −6.19 |
| Diluted shares (millions) | 30 | 30 | 31 | 31 | 31 | 31 | 42 | 54 | 54 | 55 |
| Cash flow | ||||||||||
| Cash from operations | 130 | 131 | 139 | 160 | 162 | 58 | 202 | 107 | 95 | 134 |
| Capital expenditure | 28 | 37 | 27 | 29 | 30 | 19 | 46 | 66 | 55 | 40 |
| Free cash flow | 102 | 94 | 112 | 132 | 132 | 39 | 157 | 41 | 40 | 94 |
| Dividends paid | 49 | 52 | 53 | 54 | 55 | 55 | 72 | 55 | 22 | 22 |
| Share buybacks | 1 | 1 | 3 | 1 | 1 | 3 | 7 | 11 | 0 | 0 |
| Acquisitions | 0 | 292 | 0 | 0 | 169 | 630 | 462 | 0 | 0 | 0 |
| Stock-based compensation | 6 | 7 | 5 | 8 | 9 | 8 | 20 | 10 | 11 | 11 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 107 | 107 | 94 | 103 | 55 | 71 | 101 | 120 | 94 | 84 |
| Debt incl. finance leases | 447 | 692 | 637 | 555 | 601 | 1,289 | 1,742 | 1,148 | 1,131 | 1,052 |
| Total assets | 1,174 | 1,542 | 1,466 | 1,472 | 1,585 | 2,420 | 3,669 | 2,642 | 2,448 | 2,052 |
| Total liabilities | 665 | 996 | 909 | 874 | 935 | 1,738 | 2,490 | 1,693 | 1,589 | 1,553 |
| Shareholders' equity | 508 | 547 | 558 | 598 | 650 | 682 | 1,179 | 949 | 858 | 499 |
| Margins and ratios | ||||||||||
| Gross margin | 30.7% | 28.9% | 26.8% | 28.4% | 28.7% | 19.7% | 18.7% | 17.6% | 18.4% | 18.3% |
| Operating margin | 13.1% | 13.1% | 13.0% | 13.1% | 12.0% | −1.7% | −2.5% | −20.4% | 0.3% | −19.4% |
| Net margin | 9.9% | 3.5% | 9.1% | 8.4% | 7.8% | 9.6% | −0.4% | −15.3% | −2.5% | −17.0% |
| Free cash flow margin | 12.1% | 9.6% | 10.8% | 12.9% | 12.2% | 4.2% | 9.6% | 2.0% | 2.0% | 4.7% |
| Rule of 40 (growth + FCF margin) | 22.1% | 26.5% | 16.8% | 11.1% | 17.3% | −9.2% | 85.5% | 25.8% | −0.2% | 5.0% |
| Return on capital | 10.7% | 6.5% | 11.0% | 10.5% | 9.3% | −0.8% | −1.4% | −13.6% | 0.3% | −18.1% |
| Return on equity | 17.0% | 6.5% | 17.1% | 14.8% | 13.4% | 13.3% | −0.7% | −29.1% | −5.4% | −49.7% |
| Return on assets | 6.7% | 2.5% | 6.3% | 5.8% | 5.5% | 4.4% | −0.2% | −9.8% | −1.9% | −15.0% |
| Net debt to EBITDA | 2.2x | 3.1x | 2.8x | 2.4x | 2.8x | 23.9x | 23.5x | — | 6.9x | — |